Jasper Therapeutics Inc
JSPRW
$0.00−84.62%
At close · Oct 19, 2026
Mkt cap
$5.62K
EV/Sales
—
P/E ratio
—
Revenue (FY2019)
—
EPS (FY2019)
—
Gross Margin (FY2019)
—
Profit Margin (FY2019)
—
Beta
2.73
Div yield
—
Sector
Healthcare
What matters now, from SEC filings and analyst ratings
Takeaway
A takeaway appears here once the latest filing has been analyzed.
Analysts
Sector-relative grades for valuation, growth, profitability, momentum and revisions
Form 4 trades, last 90 days
Latest SEC filings
Source: SEC EDGAR · Latest filing Oct 1, 2026
Latest stored headlines
Jasper Therapeutics Inc (JSPRW) is a biotechnology company listed on US.
Use this JSPRW research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full JSPRW income, balance, and cash tables.
Jasper Therapeutics Inc (JSPRW) is a biotechnology company in the Healthcare sector.
Latest cached Jasper Therapeutics Inc (JSPRW) net income for FY2019 was $2.0K. Statements: https://lician.com/financials/jsprw
Jasper Therapeutics Inc (JSPRW) market capitalization is $5.6K on the latest cached snapshot.
Jasper Therapeutics Inc (JSPRW) cached previous close $0.00; day range $0.00 – $0.00; volume 863,065. Session quote: https://lician.com/quote/jsprw
The latest cached JSPRW filing is 8-K/A · Oct 1, 2026. Filings: https://lician.com/sec/jsprw
Quant rating
MetricsHow it works—Not rated: no closing price in the last 7 days. Factor grades are still shown.
Lician Quant Grades · vs 561 Healthcare stocks · Nov 5, 2026
Next earnings
—
No upcoming report date on file.
Earnings
Short interest
0.21%of today’s float
1.4 days to cover
+16.4% vs prior report
FINRA · settled Sep 15Short data
Range · 185 sessions
$0.00$0.14
Last close $0.00 · 99.9% below high
Low $0.00, high $0.14, last $0.00.Daily closesChart
SEC filings · latest fiscal year FY2019
—
Revenue growth year over year
10-Q results and the earnings calendar
No reported quarter for JSPRW is stored yet (10-Q filings or the earnings calendar).
Institutional holders from SEC 13F filings